Andrew Miller has quickly made his first move after the technology he invented, KarXT, secured an FDA approval last week. The ...

Alnylam Pharmaceuticals has agreed to drop its 2023 patent lawsuit against Moderna in a Delaware court following a judge's ...

This season’s uptake of RSV vaccines in the US has been slower than expected, according to Wall Street analysts tracking ...

Flagship Pioneering's roots in Singapore are growing less than a year after the biotech incubator first unveiled its ...

The European Medicines Agency is looking more closely at medicines used to treat hair loss and a condition caused by an ...

Telehealth companies and patients are grappling with the potential loss of access to cheaper, alternative versions of Eli ...

What’s left of Johnson & Johnson’s infectious disease work continues to shrink, after the company announced Friday that it ...

Sanofi is offloading its rare autoimmune disease medicine Enjaymo to an Italian pharmaceutical company for $825 million ...

Triveni Bio became the latest immunology and inflammation startup this year to announce a $100 million-plus financing round.

Eli Lilly’s blockbuster GLP-1 drug tirzepatide is finally back on track in the US after two years of intermittent shortages ...

WuXi AppTec and WuXi Biologics are reportedly looking to sell part of their operations that have struggled because of ...

The UK’s publicly funded healthcare system has proposed phasing its rollout of Eli Lilly’s weight loss treatment tirzepatide ...